Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Peter R Wilson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unitJorge Cepeda, Samantha Hayman, Tony Whitehouse, et al.
The Journal of Antimicrobial Chemotherapy|October 2, 2003
Variability of treatment duration for bacteraemia in the critically ill: a multinational surveyAlberto Corona, Guido Bertolini, Anna Maria Ricotta, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2018
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working PartyPeter M Hawkey, Roderic E Warren, David M Livermore, et al.
BMC Infectious Diseases|August 4, 2012
Use of UV-C radiation to disinfect non-critical patient care items: a laboratory assessment of the Nanoclave CabinetGinny Moore, Shanom Ali, Elaine A Cloutman-Green, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2005
Pharmacokinetic studies of linezolid and teicoplanin in the critically illTony Whitehouse, Jorge A Cepeda, Rob Shulman, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2004
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre studyJorge A Cepeda, Tony Whitehouse, Ben Cooper, et al.
The Journal of Infection|September 19, 2021
Risk factors associated with bloodstream infections among critically ill patients with COVID-19Tim McMillan, Conor Jones, Cavan J O'Connor, et al.
Critical Care Medicine|January 19, 2011
The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitalsA Peter R Wilson, Deborah Smyth, Ginny Moore, et al.
Lancet (London, England)|January 25, 2005
Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre studyJorge A Cepeda, Tony Whitehouse, Ben Cooper, et al.
Microorganisms|January 25, 2025
Bloodstream Infections in Critical Care Units in England, April 2017 to March 2023: Results from the First Six Years of a National Surveillance ProgrammeOlivia D Conroy, Andrea Mazzella, Hannah Choi, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unitJorge Cepeda, Samantha Hayman, Tony Whitehouse, et al.
The Journal of Antimicrobial Chemotherapy|October 2, 2003
Variability of treatment duration for bacteraemia in the critically ill: a multinational surveyAlberto Corona, Guido Bertolini, Anna Maria Ricotta, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2018
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working PartyPeter M Hawkey, Roderic E Warren, David M Livermore, et al.
BMC Infectious Diseases|August 4, 2012
Use of UV-C radiation to disinfect non-critical patient care items: a laboratory assessment of the Nanoclave CabinetGinny Moore, Shanom Ali, Elaine A Cloutman-Green, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2005
Pharmacokinetic studies of linezolid and teicoplanin in the critically illTony Whitehouse, Jorge A Cepeda, Rob Shulman, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2004
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre studyJorge A Cepeda, Tony Whitehouse, Ben Cooper, et al.
The Journal of Infection|September 19, 2021
Risk factors associated with bloodstream infections among critically ill patients with COVID-19Tim McMillan, Conor Jones, Cavan J O'Connor, et al.
Critical Care Medicine|January 19, 2011
The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitalsA Peter R Wilson, Deborah Smyth, Ginny Moore, et al.
Lancet (London, England)|January 25, 2005
Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre studyJorge A Cepeda, Tony Whitehouse, Ben Cooper, et al.
Microorganisms|January 25, 2025
Bloodstream Infections in Critical Care Units in England, April 2017 to March 2023: Results from the First Six Years of a National Surveillance ProgrammeOlivia D Conroy, Andrea Mazzella, Hannah Choi, et al.
Pageof 3